Vicarious Surgical (RBOT) Equity Ratio (2020 - 2025)
Vicarious Surgical (RBOT) reported Equity Ratio of 0.5 for Q4 2025, down 27.12% year-over-year from 0.69 in Q4 2024, and up 4.69% on a QoQ basis from 0.48 in Q3 2025.
Vicarious Surgical (RBOT) has 6 years of Equity Ratio data on file, last reported at 0.5 in Q4 2025.
- Quarterly Equity Ratio fell 27.12% year-over-year to 0.5 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.5 (down 27.12% YoY) and the FY2025 annual result came in at 0.5, down 27.12% from the prior year.
- Equity Ratio rose to 0.5 in Q4 2025 per RBOT's latest filing, from 0.48 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.82 in Q4 2023 and bottomed at 0.12 in Q2 2021.
- The 5-year median for Equity Ratio is 0.72 (2024), against an average of 0.59.
- The widest annual swing landed in 2022, when Equity Ratio soared 810.44%; it then tumbled 33.14% in 2025.
- Tracing RBOT's Equity Ratio over 5 years: stood at 0.46 in 2021, then surged by 73.07% to 0.79 in 2022, then grew by 3.26% to 0.82 in 2023, then retreated by 15.63% to 0.69 in 2024, then declined by 27.12% to 0.5 in 2025.
- Per Business Quant, the three latest RBOT Equity Ratio figures stand at 0.5 (Q4 2025), 0.48 (Q3 2025), and 0.56 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | Vicarious Surgical | - | - | - | 0.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.50 |
| Sep 30, 2025 | 0.48 |
| Jun 30, 2025 | 0.56 |
| Mar 31, 2025 | 0.62 |
| Dec 31, 2024 | 0.69 |
| Sep 30, 2024 | 0.72 |
| Jun 30, 2024 | 0.77 |
| Mar 31, 2024 | 0.80 |
| Dec 31, 2023 | 0.82 |
| Sep 30, 2023 | 0.82 |
| Jun 30, 2023 | 0.72 |
| Mar 31, 2023 | 0.72 |
| Dec 31, 2022 | 0.79 |
| Sep 30, 2022 | 0.72 |
| Jun 30, 2022 | 0.79 |
| Mar 31, 2022 | 0.71 |
| Dec 31, 2021 | 0.46 |
| Sep 30, 2021 | 0.30 |
| Jun 30, 2021 | -0.12 |
| Mar 31, 2021 | -0.10 |
| Dec 31, 2020 | -1.68 |
| Sep 30, 2020 | 0.06 |
| Jun 30, 2020 | -59.74 |